Reilly Financial Advisors Holding in Abbott Labs (ABT) Has Lowered by $1.40 Million as Market Valuation Rose; As Trupanion (TRUP) Share Value Declined, Petrus Trust Company Lta Has Trimmed Stake by $7.72 Million

May 22, 2018 - By Matt Maslow

Trupanion, Inc. (NASDAQ:TRUP) Logo

Petrus Trust Company Lta decreased its stake in Trupanion Inc (TRUP) by 57.11% based on its latest 2017Q4 regulatory filing with the SEC. Petrus Trust Company Lta sold 266,271 shares as the company’s stock declined 2.28% with the market. The institutional investor held 200,000 shares of the health care company at the end of 2017Q4, valued at $5.85 million, down from 466,271 at the end of the previous reported quarter. Petrus Trust Company Lta who had been investing in Trupanion Inc for a number of months, seems to be less bullish one the $940.29M market cap company. The stock decreased 1.41% or $0.43 during the last trading session, reaching $30.15. About 187,688 shares traded. Trupanion, Inc. (NYSE:TRUP) has risen 105.49% since May 22, 2017 and is uptrending. It has outperformed by 93.94% the S&P500.




Reilly Financial Advisors Llc decreased its stake in Abbott Labs (ABT) by 11.26% based on its latest 2017Q4 regulatory filing with the SEC. Reilly Financial Advisors Llc sold 24,533 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 193,278 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $11.03M, down from 217,811 at the end of the previous reported quarter. Reilly Financial Advisors Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $107.63 billion market cap company. The stock decreased 1.16% or $0.72 during the last trading session, reaching $61.39. About 6.80M shares traded or 8.26% up from the average. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 22, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Analysts await Trupanion, Inc. (NASDAQ:TRUP) to report earnings on August, 7. They expect $-0.05 earnings per share, down 150.00% or $0.03 from last year’s $-0.02 per share. After $-0.05 actual earnings per share reported by Trupanion, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 8 analysts covering Trupanion (NYSE:TRUP), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Trupanion had 19 analyst reports since July 19, 2016 according to SRatingsIntel. The rating was maintained by Northland Capital on Thursday, February 8 with “Buy”. C.L. King initiated the stock with “Hold” rating in Tuesday, November 21 report. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, February 14 report. The firm has “Buy” rating given on Thursday, November 2 by Stifel Nicolaus. As per Friday, May 6, the company rating was maintained by RBC Capital Markets. The company was maintained on Wednesday, August 2 by Canaccord Genuity. The stock of Trupanion, Inc. (NASDAQ:TRUP) has “Buy” rating given on Friday, November 3 by Cowen & Co. Northland Capital maintained Trupanion, Inc. (NASDAQ:TRUP) rating on Friday, November 3. Northland Capital has “Buy” rating and $31.5 target. RBC Capital Markets maintained it with “Buy” rating and $26.0 target in Thursday, September 21 report. As per Tuesday, October 31, the company rating was maintained by Canaccord Genuity.

More important recent Trupanion, Inc. (NASDAQ:TRUP) news were published by: Nasdaq.com which released: “Trupanion Announces Date of 2018 Annual Meeting of Stockholders” on April 27, 2018, also Globenewswire.com published article titled: “Trupanion Reports First Quarter 2018 Results”, Globenewswire.com published: “Trupanion Recommends National Disaster Preparedness with Your Pet in Mind” on May 09, 2018. More interesting news about Trupanion, Inc. (NASDAQ:TRUP) was released by: Globenewswire.com and their article: “Recent Analysis Shows Beneficial, TopBuild, Gibraltar Industries, Earthstone Energy, Trupanion, and Heidrick …” with publication date: May 22, 2018.

Petrus Trust Company Lta, which manages about $403.64 million US Long portfolio, upped its stake in Blackhawk Network Hldgs Inc (NASDAQ:HAWK) by 29,400 shares to 178,900 shares, valued at $6.38M in 2017Q4, according to the filing. It also increased its holding in Procter And Gamble Co (NYSE:PG) by 6,253 shares in the quarter, for a total of 61,964 shares, and has risen its stake in Antero Midstream Partners Lp (NYSE:AM).

More important recent Abbott Laboratories (NYSE:ABT) news were published by: Streetinsider.com which released: “JPMorgan Remains Positive on Abbott (ABT), Expects Limited Impact from LVAD Recall” on May 22, 2018, also Benzinga.com published article titled: “WHO Deems The Products Of These Diagnostic Companies ‘Essential'”, Seekingalpha.com published: “Abbott’s stent guide improved outcomes in long-term study” on May 22, 2018. More interesting news about Abbott Laboratories (NYSE:ABT) was released by: Streetinsider.com and their article: “Abbott (ABT) Reports 5-Yr FAME 2 Study Showing Positive Outcomes of Patients Using Diagnostic Tool” with publication date: May 22, 2018.

Reilly Financial Advisors Llc, which manages about $679.11 million and $704.29 million US Long portfolio, upped its stake in Halliburton Co (NYSE:HAL) by 7,335 shares to 35,677 shares, valued at $1.74M in 2017Q4, according to the filing. It also increased its holding in Kimberly Clark Corp (NYSE:KMB) by 75,074 shares in the quarter, for a total of 77,465 shares, and has risen its stake in Mondelez Intl Inc (NASDAQ:MDLZ).

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Tuesday, July 11 with “Equal-Weight”. The firm earned “Buy” rating on Tuesday, January 2 by Guggenheim. The firm earned “Neutral” rating on Friday, October 6 by JP Morgan. The company was upgraded on Tuesday, January 2 by JP Morgan. The stock has “Buy” rating by Guggenheim on Thursday, January 25. The rating was maintained by RBC Capital Markets on Thursday, July 23 with “Outperform”. The firm has “Buy” rating given on Wednesday, January 24 by RBC Capital Markets. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Monday, December 7 by Jefferies. The firm has “Outperform” rating given on Monday, August 10 by Credit Suisse. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, October 19.

Since December 14, 2017, it had 1 insider purchase, and 20 selling transactions for $23.69 million activity. Fussell Stephen R sold $667,804 worth of stock or 11,106 shares. Watkin Jared sold $17,609 worth of stock or 297 shares. 459 shares valued at $27,213 were sold by PEDERSON MICHAEL J on Friday, February 16. 1,645 shares valued at $96,728 were sold by BIRD ROGER on Wednesday, February 28. Salvadori Daniel Gesua Sive sold $1.56M worth of stock or 28,319 shares. Another trade for 40,037 shares valued at $2.43 million was made by STARKS DANIEL J on Tuesday, February 27.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Maryland holds 374,021 shares or 3.16% of its portfolio. Nuwave Invest Mgmt Ltd Liability reported 710 shares. Kemper Corp Master Retirement Tru stated it has 1.62% of its portfolio in Abbott Laboratories (NYSE:ABT). First Pacific Advsrs Ltd Liability Corporation holds 0% or 7,700 shares in its portfolio. First Hawaiian National Bank owns 0.1% invested in Abbott Laboratories (NYSE:ABT) for 13,767 shares. Haverford Trust reported 85,779 shares stake. Oregon Pub Employees Retirement Fund holds 0.16% or 184,801 shares. Samlyn Capital Llc accumulated 594,162 shares. Abner Herrman And Brock Lc reported 206,342 shares. Great Lakes Advsr Limited Liability holds 1.56% of its portfolio in Abbott Laboratories (NYSE:ABT) for 1.24 million shares. Cibc World Markets holds 0.03% or 115,145 shares in its portfolio. Waters Parkerson And Com Llc has invested 2.5% in Abbott Laboratories (NYSE:ABT). Jefferies Gru Lc has invested 0.01% in Abbott Laboratories (NYSE:ABT). Cannell Peter B reported 1.03M shares. Ajo LP invested in 0.03% or 124,100 shares.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24 billion for 21.62 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts